Patent · US Active

Inhibitors of serine proteases

US8372873B2 · kind B2 · utility

1Cited by
107References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 29, 2011
Grant dateFeb 12, 2013
Priority date
Expiry dateMar 29, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K5/06034
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula (I):or a pharmaceutically acceptable salt thereof. These compounds inhibit serine protease, particularly the hepatitis C virus NS3-NS4A protease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.